Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis.
Saved in:
| Title: | Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis. |
|---|---|
| Authors: | Rubio‐Rivas, Manuel1 (AUTHOR) mrubio@bellvitgehospital.cat, Forero, Carlos G.2 (AUTHOR), Mora‐Luján, José María1 (AUTHOR), Montero, Abelardo1 (AUTHOR), Formiga, Francesc1 (AUTHOR), Homs, Narcís A.1 (AUTHOR), Albà‐Albalate, Joan1 (AUTHOR), Sánchez, Laura1 (AUTHOR), Rello, Jordi2,3,4 (AUTHOR), Corbella, Xavier1,2 (AUTHOR) |
| Source: | Pharmacotherapy. Nov2021, Vol. 41 Issue 11, p884-906. 23p. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 153677337 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Rubio‐Rivas%2C+Manuel%22">Rubio‐Rivas, Manuel</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> mrubio@bellvitgehospital.cat</i><br /><searchLink fieldCode="AR" term="%22Forero%2C+Carlos+G%2E%22">Forero, Carlos G.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mora‐Luján%2C+José+María%22">Mora‐Luján, José María</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Montero%2C+Abelardo%22">Montero, Abelardo</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Formiga%2C+Francesc%22">Formiga, Francesc</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Homs%2C+Narcís+A%2E%22">Homs, Narcís A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Albà‐Albalate%2C+Joan%22">Albà‐Albalate, Joan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sánchez%2C+Laura%22">Sánchez, Laura</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rello%2C+Jordi%22">Rello, Jordi</searchLink><relatesTo>2,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Corbella%2C+Xavier%22">Corbella, Xavier</searchLink><relatesTo>1,2</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Pharmacotherapy%22">Pharmacotherapy</searchLink>. Nov2021, Vol. 41 Issue 11, p884-906. 23p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=153677337 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/phar.2627 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 23 StartPage: 884 Titles: – TitleFull: Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rubio‐Rivas, Manuel – PersonEntity: Name: NameFull: Forero, Carlos G. – PersonEntity: Name: NameFull: Mora‐Luján, José María – PersonEntity: Name: NameFull: Montero, Abelardo – PersonEntity: Name: NameFull: Formiga, Francesc – PersonEntity: Name: NameFull: Homs, Narcís A. – PersonEntity: Name: NameFull: Albà‐Albalate, Joan – PersonEntity: Name: NameFull: Sánchez, Laura – PersonEntity: Name: NameFull: Rello, Jordi – PersonEntity: Name: NameFull: Corbella, Xavier IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2021 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 02770008 Numbering: – Type: volume Value: 41 – Type: issue Value: 11 Titles: – TitleFull: Pharmacotherapy Type: main |
| ResultId | 1 |